Spire Healthcare Group plc
SPI.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | £25,400 | £27,300 | £8,600 | -£9,700 |
| Dep. & Amort. | £112,200 | £103,600 | £97,900 | £97,100 |
| Deferred Tax | £0 | £0 | -£197,500 | -£183,300 |
| Stock-Based Comp. | £4,700 | £3,700 | £2,300 | £2,800 |
| Change in WC | -£16,000 | -£15,500 | -£15,000 | £11,400 |
| Other Non-Cash | £109,400 | £96,400 | £264,200 | £252,300 |
| Operating Cash Flow | £235,700 | £199,900 | £160,500 | £170,600 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£109,300 | -£84,400 | -£87,700 | -£69,300 |
| Net Acquisitions | £0 | -£73,200 | -£10,800 | -£14,600 |
| Inv. Purchases | £0 | £0 | £7,600 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £500 | £400 |
| Other Inv. Act. | £10,300 | £400 | -£7,600 | £35,200 |
| Investing Cash Flow | -£99,000 | -£157,200 | -£98,000 | -£48,300 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -£26,200 | £40,000 | -£100,000 | -£14,700 |
| Stock Issued | £0 | -£600 | £3,100 | £0 |
| Stock Repurch. | -£11,600 | -£3,100 | £0 | £0 |
| Dividends Paid | -£8,500 | -£2,000 | -£100 | £0 |
| Other Fin. Act. | -£98,800 | -£117,200 | -£93,900 | -£11,300 |
| Financing Cash Flow | -£145,100 | -£82,900 | -£190,900 | -£26,000 |
| Forex Effect | £0 | £0 | £0 | £0 |
| Net Chg. in Cash | -£8,400 | -£24,600 | -£128,400 | £96,300 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £49,600 | £74,200 | £202,600 | £106,300 |
| End Cash | £41,200 | £49,600 | £74,200 | £202,600 |
| Free Cash Flow | £123,600 | £115,500 | £72,800 | £101,300 |